Additional information
| Active substance | GHRH Peptide |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Monitoring of IGF-1 levels may be used to assess efficacy |
| Also known as | TH9507 |
| WAREHOUSE | International Warehouse 3 |
| Blood pressure | Typically no significant impact on blood pressure |
| Trade name | Egrifta |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) |
| Chemical name | (trans-3-Hexenoyl)lysyl-threonyl-threonyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl |
| Formula | C221H366N72O67S |
| Substance class | Peptide hormone |
| Main action | Growth hormone-releasing hormone (GHRH) analog |
| Half-life | Approximately 38 minutes |
| Dosage (medical) | 2 mg injected subcutaneously once daily |
| Dosage (sports) | Not applicable as it is not typically used for sports enhancement |
| Effects | Increases natural production of growth hormone |
| Side effects | Injection site reactions (redness, itching, pain), muscle aches, swelling, and potential increase in blood sugar levels |
| Use in sports | Not commonly used due to its specific medical application for reducing excess abdominal fat in HIV-infected patients with lipodystrophy |
| Manufacturer | Beligas |
Fostimon (Merional) 75 (HMG) IBSA
FACTIVE 320 mg Abdi Ibragim
AVELOX 400 Bayer
Zyban Glaxosmithkline
Spiriva HandiHaler 18mg Boehringer Ingelheim
Zimaks 400 Bilim
Fostimon (Merional) 150 IU HMG IBSA
Januvia 100mg Merckgroup
LACIPIL 4 mg Glaxosmithkline
Champix 56 tabs Pfizer
SOMATROX XT LABS 

Reviews
There are no reviews yet.